CLINICAL_TRIALS
trial_result
· 2012-10-12
Clinical Trial Update: Efficacy and Safety of OMS103HP in Patients Undergoing Allograft Anterior Cruciate Ligament (ACL) Reconstruction [Phase 3]
Summary
Phase 3 trial assessing the efficacy and safety of OMS103HP in patients undergoing allograft anterior cruciate ligament reconstruction has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Omeros Corporation | Conditions: Knee Injuries | Phase 3 | Status: COMPLETED